Join to View Full Profile
1800 Mulberry StScranton, PA 18510
Phone+1 570-703-8000
Fax+1 570-703-8002
Dr. Koch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Koch Jr. is an oncologist based in Scranton, PA, specializing in hematologic conditions such as amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. He completed his fellowship in Hematology and Medical Oncology at the UCLA David Geffen School of Medicine/UCLA Medical Center from 1979 to 1982, following a residency in Internal Medicine at The MetroHealth System/Case Western Reserve University. Dr. Koch graduated from Case Western Reserve University School of Medicine in 1976. His research includes publications on hepatotoxicity and liver damage mechanisms in peer-reviewed journals, which have been cited multiple times by other scholars in the field.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1982
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1976 - 1979
Case Western Reserve University School of MedicineClass of 1976
Certifications & Licensure
FL State Medical License 1982 - 2027
PA State Medical License 2015 - 2026
GU State Medical License Active through 2025
NC State Medical License 2000 - 2025
HI State Medical License 2018 - 2022
MA State Medical License 2017 - 2022
NM State Medical License 2015 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 59 citationsHepatotoxicity of bromotrichloromethane— bond dissociation energy and lipoperoxidation☆Robert R. Koch, Eric A. Glende, Richard O. Recknagel
Biochemical Pharmacology. 1974-10-15 - 37 citationsReversibility of liver damage in rats rendered resistant to carbon tetrachloride by prior carbon tetrachloride administration: Bearing on the lipoperoxidation hypothesisGiancarlo Ugazio, Robert R. Koch, Richard O. Recknagel
Experimental and Molecular Pathology. 1973-06-01 - 57 citationsMechanism of protection against carbon tetrachloride by prior carbon tetrachloride administration.Giancarlo Ugazio, Robert R. Koch, Richard O. Recknagel
Experimental and Molecular Pathology. 1972-06-01
Press Mentions
Raymond L. Erikson, PhD: In Memoriam (1936–2020)June 5th, 2020- The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-like PhenotypeMay 18th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
